|
|||||
|
|
Ofatumumab‐based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL) |
|
| Authors: | Tait Shanafelt MD Mark C. Lanasa MD Timothy G. Call MD Anne W. Beaven MD Jose F. Leis MD Betsy LaPlant MS Deborah Bowen NP Michael Conte PA Diane F. Jelinek PhD Curtis A. Hanson MD Neil E. Kay MD Clive S. Zent MD |
| Affiliation: | 1. Mayo Clinic, , Rochester, Minnesota;2. Duke University, , Durham, North Carolina |
| Abstract: | |
| Keywords: | chronic lymphocytic leukemia small lymphocytic lymphoma treatment ofatumumab rituximab pentostatin fludarabine chemoimmunotherapy |